GGrantIndex
Sort

53,477 grants matching addiction

Oxytocin and drug extinction in prairie voles

$718,146
Mohamed Kabbaj · Florida State University · R01 · FY2025 · DA

Maternal Opioid Treatment: Human Experimental Research

$717,964
Karol Kaltenbach · Thomas Jefferson University · R01 · FY2007 · DA

Prazosin Treatment for Alcohol Use Disorder with Alcohol Withdrawal Symptoms

$717,796
Rajita Sinha · Yale University · R01 · FY2023 · AA

Molecular mechanisms of memory maintenance and dysfunction in neural circuits

$717,788
Todd C Sacktor · Suny Downstate Medical Center · R01 · FY2020 · MH

Data Driven Strategies for Substance Misuse Identification in Hospitalized Patients

$717,699
Majid Afshar · University Of Wisconsin-Madison · R01 · FY2022 · DA

Regulation of Craving: Clinical Trial and Neural Mechanisms

$717,692
Hedy Kober · Yale University · R01 · FY2023 · AA

A Type I Hybrid Effectiveness-Implementation Trial of "Mothering from the Inside Out" (MIO)

$717,691
Elizabeth Peacock-Chambers · Baystate Medical Center, Inc. · R01 · FY2025 · DA

Prescription Opioid Misuse: A Pharmacist-Led Intervention at Point of Service Efficacy Trial

$717,674
Gerald T. Cochran · University Of Utah · R01 · FY2024 · DA

Statewide System and Organizational Strategy for Evidence-Based Practice Implementation and Sustainment in Substance Use Disorder Treatment

$717,590
Gregory Aarons · University Of California, San Diego · R01 · FY2021 · DA

Mobile Phone Enabled HIV Prevention and Treatment Interventions for Health Disparity Populations in South Los Angeles

$717,500
Jaydutt V Vadgama · Charles R. Drew University Of Med & Sci · U54 · FY2021 · MD

Mindfulness-Based Relapse Prevention: Efficacy and Mechanisms

$717,464
G Alan Marlatt · University Of Washington · R01 · FY2009 · DA

Behavioral Phenotyping Core

$717,378
Leona Gagnon · Jackson Laboratory · P50 · FY2022 · DA

Effectiveness of an mHealth psychosocial intervention to prevent transition from acute to chronic postsurgical pain in adolescents

$717,363
Jennifer Rabbitts · Seattle Children'S Hospital · UG3 · FY2019 · HD

Molecular mechanisms and functions underlying the role of Fto in mu opioid actions

$717,345
Ying-Xian Pan · Rutgers Biomedical And Health Sciences · R01 · FY2025 · DA

Mechanistic dissection and inhibitor targeting of autophagy in RAS driven cancers

$717,245
Kirsten L Bryant · Univ Of North Carolina Chapel Hill · R37 · FY2025 · CA

A Proof-of-Concept Trial of N-Acetylcysteine for Adolescent Alcohol Use Disorder

$717,092
Kevin M Gray · Medical University Of South Carolina · R01 · FY2020 · AA

Hypothalamic-Pituitary-Adrenal Axis and Alcoholism

$717,079
Gary S Wand · Johns Hopkins University · R01 · FY2010 · AA

Changing our paths: Well-being and recovery among American Indians with opioid use disorder

$717,051
Brenna Greenfield · University Of Minnesota · R33 · FY2024 · DA

A Biopsychobehavioral Investigation of Withdrawal from Ultra-Processed Food in Humans

$717,025
Ashley Nicole Gearhardt · University Of Michigan At Ann Arbor · R01 · FY2022 · DA

Structure Function of CB1 Cannabinoid Receptor

$716,981
Raymond C Stevens · University Of Southern California · R01 · FY2018 · DA

Structure Function of CB1 Cannabinoid Receptor

$716,981
Raymond C Stevens · University Of Southern California · R01 · FY2017 · DA

Structure Function of CB1 Cannabinoid Receptor

$716,981
Alexandros Makriyannis · University Of Southern California · R01 · FY2019 · DA

Structure Function of CB1 Cannabinoid Receptor

$716,981
Vsevolod Katritch · University Of Southern California · R01 · FY2020 · DA

Determining the Contributions of Four AARDoC Functional Domains to the Etiology of Heavy Drinking and AUD Symptoms: A Prospective, Multimodal Approach

$716,915
Bruce D Bartholow · University Of Iowa · R01 · FY2024 · AA

Western States Node of the National Drug Abuse Treatment Clinical Trials Network

$716,901
James L. Sorensen · University Of California, San Francisco · UG1 · FY2016 · DA